"I look forward to working closely with the board and management of CTI BioPharma to help the company reach the next level of success as it develops and commercializes innovative therapeutics," said Mr. Metzger. "CTI Biopharma is at a transformation point with an opportunity to address an important unmet need in myelofibrosis with pacritinib and I am excited to join their efforts